Biotech IV Monitor

GILD — Gilead Sciences Inc.

$183.0B market cap · 8 upcoming readouts tracked

Clinical trial readout dates for Gilead Sciences Inc., compiled from ClinicalTrials.gov, alongside the SEC filings where results are announced. The next expected readout is December 2026.

Next readoutDecember 2026in ~1 month
Upcoming readouts83 Phase 3
Market cap$183.0B
Recent 8-K filings1latest 2026-10-29

Recently completed

The registry reports these trials have finished collecting primary data. Results often follow within months, and the company may already have reported.

Phase 2 Lenacapavir Injection
Pre-Exposure Prophylaxis of HIV Infection · NCT06101342
July 2026
Primary data collected
Phase 2 Lenacapavir Tablet
Pre-Exposure Prophylaxis of HIV Infection · NCT06101329
July 2026
Primary data collected
Phase 2 Lenacapavir Injection
Pre-Exposure Prophylaxis of HIV Infection · NCT06513312
May 2026
Primary data collected

Upcoming readouts

Phase 3 Sacituzumab Govitecan-hziy
Metastatic Breast Cancer · NCT04639986
December 2026
Ongoing
Phase 2 Tilpisertib Fosmecarbil
Ulcerative Colitis · NCT06029972
January 2027
Ongoing
Phase 3 Sacituzumab Govitecan-hziy
Triple Negative Breast Cancer; PD-L1 Positive · NCT05382286
February 2027
Ongoing
Phase 2 Oral Lenacapavir
HIV-1-infection · NCT06749054
March 2027
Recruiting
Phase 2 Sacituzumab Govitecan-hziy (SG)
Non-small Cell Lung Cancer · NCT05186974
March 2027
Ongoing
Phase 2 Domvanalimab
Head and Neck Squamous Cell Carcinoma · NCT06727565
March 2027
Ongoing
Phase 1/2 Sacituzumab Govitecan-hziy
Advanced Solid Tumor; Metastatic Triple-Negative Breast Cancer · NCT05101096
May 2027
Ongoing
Phase 3 Sacituzumab govitecan-hziy (SG)
Triple Negative Breast Cancer · NCT05633654
June 2027
Recruiting

Recent SEC filings

8-K Results of Operations — earnings, may carry pipeline updates2026-10-29

Companies working on similar indications

Discussion

No messages yet. If you follow GILD, you can start the conversation.
Track GILD in real time
See live implied volatility for GILD and 106 other biotechs, and get alerted when a readout lands.
🔔 Alert me on GILD
Contact — questions or corrections about GILD: dukeupt@gmail.com